Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,735
Closed -$207K 193
2026
Q1
$207K Buy
+2,735
New +$206K 0.08% 168

Other funds holding HOLX

DoubleLine ETF Adviser's HOLX Position: Q2 2026 in Review

DoubleLine ETF Adviser sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,735 shares — an estimated $207K sold.

DoubleLine ETF Adviser first reported a position in HOLX in Q1 2026 and held it in 1 quarter. The position peaked at $207K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • DoubleLine ETF Adviser reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • DoubleLine ETF Adviser sold 2,735 Hologic shares in Q2 2026, an estimated $207K.
  • DoubleLine ETF Adviser first reported a position in Hologic in Q1 2026 and held it in 1 quarter.
  • DoubleLine ETF Adviser's Hologic position peaked at $207K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.